Proscia

SpecialtyVETPATH Taps Proscia For A Full Transformation Of Its Pathology Operations

SEATTLE and PHILADELPHIA – April 23, 2024 – SpecialtyVETPATH, a private, pathologist-owned, and pathologist-directed veterinary pathology laboratory, has selected Proscia®, a leading provider of digit...

QDx Pathology Services Adopts Proscia’s Software To Improve Speed And Precision

Empowering its pathologists and advancing its practice with innovation EDISON, N.J. and PHILADELPHIA – March 19, 2024 – QDx Pathology Services, an independent anatomical, molecular, and clinical patho...

Pramana Joins Proscia Ready To Help Laboratories Realize More Value From Their Pathology Data

Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images CAMBRIDGE, Mass. and PHILADELPHIA  – February 27, 2024 – Proscia®, a leading provider of digital and co...

Proscia Forms New Alliance To Help Laboratories Accelerate Scaled Adoption Of Digital Pathology With Confidence

Proscia Ready advances increasingly comprehensive approach for realizing the full promise of digitization BY AUTHOR PROSCIA | FEBRUARY 20, 2024 PHILADELPHIA – February 20, 2024 –Proscia®, a lea...

Proscia Receives FDA 510(k) Clearance For Concentriq AP-Dx

Key regulatory milestone advances company’s mission to perfect cancer diagnosis. PHILADELPHIA – February 12, 2024 – Proscia®, a leading provider of digital and computational pathology solutions, has r...

The Essential Inquiries: How Concentriq Answers Sponsors’ Most Pressing Pathology Questions for CROs

BY JIM FISCHER | JANUARY 18, 2024 In the challenging and lengthy process of drug development, which typically spans 10 to 15 years and costs an estimated $2.6 billion (1), a dynamic shift is occ...

Lessons To Learn From The UK’s Pathology Challenges And Its Technology-Centric Strategy To Deliver Quality Diagnostic Services

BY NATHAN BUCHBINDER | JANUARY 11, 2024 The United Kingdom (UK) National Screening Committee recently released a recommendation on the critical role of digital pathology, and, in response, the g...

The ACSR Democratizes Access To Pathology Data With Proscia, Advancing Breakthroughs For HIV Cancer Patients

Distributing real-world data to researchers in hours instead of days SAN FRANCISCO and PHILADELPHIA – December 12, 2023 – The AIDS and Cancer Specimen Resource (ACSR), a biorepository of specimens col...

CellNetix Selects Proscia To Deliver New Standard Of Excellence In Pathology

Modernizing the 150-year-old microscope-based practice with digital innovation TUKWILA, WASH. and PHILADELPHIA – December 6, 2023 – CellNetix Pathology & Laboratories, one of the largest independe...

  • 1
  • 2
  • 7